The Oncology Institute of Hope and Innovation — Anaheim, California

The Oncology Institute of Hope and Innovation is a clinical research site located in Anaheim, California, United States 92801.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

The Oncology Institute of Hope and Innovation has participated in 4 clinical trials.

Therapeutic areas: Squamous Cell Carcinoma of the Head and Neck, Follicular Lymphoma, Metastatic Colorectal Cancer.

Sponsors: Pfizer, Menarini Group, Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Oncology Institute of Hope and Innovation?

The Oncology Institute of Hope and Innovation has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Oncology Institute of Hope and Innovation conducted?

The Oncology Institute of Hope and Innovation has 4 clinical trials on record. Their work covers Squamous Cell Carcinoma of the Head and Neck, Follicular Lymphoma, Metastatic Colorectal Cancer.

Is The Oncology Institute of Hope and Innovation accredited by Crixeo Health?

The Oncology Institute of Hope and Innovation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Oncology Institute of Hope and Innovation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.